| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AJOG.2007.08.003 |
| P8608 | Fatcat ID | release_jjiefpfswfahlo4ao6mdajw3ca |
| P932 | PMC publication ID | 2112746 |
| P698 | PubMed publication ID | 17980189 |
| P5875 | ResearchGate publication ID | 5866824 |
| P2093 | author name string | Joan L Walker | |
| Donald G Gallup | |||
| Frederick B Stehman | |||
| Shamshad Ali | |||
| Laila I Muderspach | |||
| Deborah Gersell | |||
| Henry M Keys | |||
| Weldon E Chafe | |||
| P2860 | cites work | Evaluation of survival data and two new rank order statistics arising in its consideration | Q34054360 |
| Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. | Q34374619 | ||
| Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study | Q40380436 | ||
| Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. | Q44780583 | ||
| Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial | Q45274577 | ||
| Long-term results of treatment of cervical carcinoma in the United States in 1973, 1978, and 1983: Patterns of Care Study (PCS). | Q50114409 | ||
| Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study. | Q53264343 | ||
| Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud | Q53346033 | ||
| Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix | Q57618646 | ||
| Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group | Q73507149 | ||
| Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix | Q73675166 | ||
| Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer | Q77321070 | ||
| Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer | Q77321076 | ||
| Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma | Q77321080 | ||
| Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix | Q77639619 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| cisplatin | Q412415 | ||
| gynecologic oncology | Q5625186 | ||
| P304 | page(s) | 503.e1-6 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | American Journal of Obstetrics and Gynecology | Q4744256 |
| P1476 | title | Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial | |
| P478 | volume | 197 |
| Q28072331 | A practical review of magnetic resonance imaging for the evaluation and management of cervical cancer |
| Q46021039 | Adjuvant chemoradiation after laparoscopically assisted vaginal radical hysterectomy (LARVH) in patients with cervical cancer: oncologic outcome and morbidity. |
| Q36055218 | Alcohol Abuse Decreases Pelvic Control and Survival in Cervical Cancer: An Opportunity of Lifestyle Intervention for Outcome Improvement |
| Q33873056 | American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer |
| Q37114187 | Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients |
| Q39278591 | Cervical cancer: A global health crisis |
| Q37806149 | Chemoradiotherapy for cervical cancer in 2010 |
| Q38643452 | Comparison of systemic therapies used concurrently with radiation for the treatment of human papillomavirus-associated oropharyngeal cancer |
| Q38626522 | Concurrent Chemoradiation for Cancer of the Cervix: Results of a Multi-Institutional Study From the Setting of a Developing Country (India). |
| Q36766837 | Concurrent cisplatin-based chemoradiotherapy versus exclusive radiotherapy in high-risk cervical cancer: a meta-analysis. |
| Q38975263 | Contemporary Role of Radiotherapy in the Management of Primary Penile Tumors and Metastatic Disease |
| Q47104015 | Contemporary role of radiotherapy in the management of penile cancer |
| Q54997619 | Correlation of cone biopsy with findings at radical hysterectomy and use of adjuvant radiation therapy |
| Q37717759 | Cost-utility analysis of treatments for stage IB cervical cancer |
| Q90039966 | Dose to pelvic lymph nodes in image based high dose rate brachytherapy of carcinoma cervix |
| Q90446654 | Dosimetric comparison of two different applicators and rectal retraction methods used in inverse optimization-based intracavitary brachytherapy for cervical cancer |
| Q37611446 | Experience in stage IB2 cervical cancer and review of treatment |
| Q33403792 | High-dose density neoadjuvant chemotherapy in bulky IB cervical cancer. |
| Q39323785 | How one institution overcame the challenges to start an MRI-based brachytherapy program for cervical cancer |
| Q42272312 | Human papillomavirus in solid organ transplantation |
| Q38103123 | Intensity modulated radiotherapy in gynecologic cancers: hope, hype or hyperbole? |
| Q49117995 | Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Treatment planning, quality control, and clinical implementation |
| Q58735914 | MicroRNA-7-5p Promotes Cisplatin Resistance of Cervical Cancer Cells and Modulation of Cellular Energy Homeostasis by Regulating the Expression of the PARP-1 and BCL2 Genes |
| Q97642102 | Organ preserving radiation strategies for penile cancer |
| Q46336740 | Palonosetron and prednisolone for the prevention of nausea and emesis during fractionated radiotherapy and 5 cycles of concomitant weekly cisplatin-a phase II study. |
| Q37703190 | Pharmacotherapy options for locally advanced and advanced cervical cancer |
| Q34850394 | Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study |
| Q36730781 | Phase III Study of Radiation Therapy With or Without Cis-Platinum in Patients With Unresectable Squamous or Undifferentiated Carcinoma of the Head and Neck: An Intergroup Trial of the Eastern Cooperative Oncology Group (E2382) |
| Q34163791 | Posttherapy residual disease associates with long-term survival after chemoradiation for bulky stage 1B cervical carcinoma: a Gynecologic Oncology Group study |
| Q64120603 | Primary Clear Cell Adenocarcinoma of the Cervix: A Clinical Analysis of 18 Cases without Exposure to Diethylstilbestrol |
| Q48552280 | Quality of life in cervical cancer survivors: patient and provider perspectives on common complications of cervical cancer and treatment |
| Q34662652 | Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers |
| Q91813335 | Radiopharmaceuticals for Persistent or Recurrent Uterine Cervix Cancer |
| Q37639494 | The Effect of Extrafascial Hysterectomy After Completion of External Beam Radiotherapy for Treatment of Locally Advanced Stages (IIB-III) of Cervical Cancer |
| Q26824965 | The need for laparoscopic ovarian transposition in young patients with cervical cancer undergoing radiotherapy |
| Q83371951 | The proper use of multimodality treatment in locally advanced cervical cancer |
| Q26829528 | The role of intensity modulated radiotherapy in gynecological radiotherapy: Present and future |
| Q38663857 | The safety of drug treatments for cervical cancer |
| Q37577185 | Treatment planning methods in high dose rate interstitial brachytherapy of carcinoma cervix: a dosimetric and radiobiological analysis |
| Q55016411 | Triapine Radiochemotherapy in Advanced Stage Cervical Cancer. |
| Q89319590 | Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years |
| Q38090265 | Upfront treatment of locally advanced cervical cancer with intensity modulated radiation therapy compared to four-field radiation therapy: a cost-effectiveness analysis |
| Q36450629 | Urinary adverse effects of pelvic radiotherapy |
| Q87423478 | [Concurrent radiochemotherapy for the treatment of solid tumors] |
Search more.